Gallacher Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Buy |
6,552
+144
| +2% | +$9.94K | 0.21% | 140 |
|
|
2025
Q1 | $445K | Buy |
6,408
+699
| +12% | +$48.5K | 0.22% | 133 |
|
|
2024
Q4 | $491K | Buy |
5,709
+57
| +1% | +$4.9K | 0.24% | 96 |
|
|
2024
Q3 | $673K | Buy |
5,652
+182
| +3% | +$21.7K | 0.31% | 58 |
|
|
2024
Q2 | $781K | Sell |
5,470
-413
| -7% | -$58.9K | 0.41% | 46 |
|
|
2024
Q1 | $755K | Sell |
5,883
-191
| -3% | -$24.5K | 0.38% | 43 |
|
|
2023
Q4 | $628K | Sell |
6,074
-242
| -4% | -$25K | 0.35% | 41 |
|
|
2023
Q3 | $574K | Buy |
6,316
+24
| +0.4% | +$2.18K | 0.36% | 47 |
|
|
2023
Q2 | $509K | Buy |
6,292
+258
| +4% | +$20.9K | 0.29% | 77 |
|
|
2023
Q1 | $480K | Sell |
6,034
-570
| -9% | -$45.3K | 0.29% | 79 |
|
|
2022
Q4 | $447K | Buy |
+6,604
| New | +$447K | 0.27% | 80 |
|